Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Quantum Biopharma Ltd

QNTM ✗ NOT COMPLIANTFree checks used up today ☆ Track — members

NASDAQ · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$1.94

▼ -3.96%

Market Cap $15.97M · Vol 17.22K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$15.97M

Micro Cap

Div Yield

N/A

Dividend with no set frequency

EPS Growth

N/A

YoY

RSI (14)

34.13

Momentum

Beta

0.48

vs Market

52W High

$12.24

84.14% below

52W Low

$1.92

1.04% above

Volume

17.22K

Avg 26.64K

P/B

4.10

Price-to-book

ROE

N/A

Return on equity

Free Float

92.36%

Public shares

Shariah Compliance8 STANDARDS

✗ Quantum Biopharma Ltd (QNTM) stock is currently not Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does QNTM pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-12.22%

-34.01%

-45.35%

-61.66%

YTD

-73.42%

-77.48%

-97.10%

-98.00%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-26,956,840.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-190.64% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	4.10
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	8.23M

Technical Indicators

50-Day SMA	$2.95
200-Day SMA	$3.71
RSI (14)	34.13
Beta	0.48
52-Week High	$12.24
52-Week Low	$1.92

Volume Today	17.22K
Avg Daily Volume (30D)	26.64K
Relative Volume	0.65x
Volatility (10D)	66.20
Volatility (30D)	61.87
Free Float	92.36%

Analyst Consensus

N/A

Current Price $1.94

Mean Target $12.50

52W Low$1.92 52W High$12.24

Current

Target

$1.92 $12.24

Current Analyst target

+544.33% upside potential · 0 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG00L1C7XW0

ISINCA74764Y2050

CountryCanada

Sub-IndustryBio Therapeutic Drugs

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co., Ltd. -1.90% ARGX.BR argenx SE +1.30% ARGX argenx SE +0.62% GMAB.CO Genmab A/S -0.56% GMAB Genmab A/S -0.37%

Company Profile

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. The Company has also licensed unbuzzd, a formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.